Duygu Ozkorucu Yıldırgan

Department of Pediatric Hematology and Oncology, Health Sciences University, Basaksehir Cam and Sakura Training and Research Hospital,, Istanbul, Turkey

Publications

• Research Article   
  Immunological and cytogenetic features, treatment management and prognosis in pediatric relapsed/refractory leukemias
  Author(s): Huseyin Avni Solgun*, Duygu Ozkorucu Yıldırgan, Ozlem Terzi and Cengiz Bayram
  
  Background: Relapsed Acute Lymphoblastic Leukemia (ALL) has remained challenging to treat in children with survival rates lagging well behind those observed at initial diagnosis. Although there have been some improvements in outcomes over the past few decades, only approximately 50% of children with first relapse of ALL survive long term, and outcome are much worse with second or later relapses. Material and Methods: In this study, 24 Patients who received leukemia treatment in the pediatric hematology and oncology clinic of our hospital between the years 2020-2023 and were diagnosed as refractory or relapsed were included. Diagnostic and treatment information such as immunophenotype, cytogenetics, treatment protocols, relapse treatment protocols, demographic data, relapse characteristics of the patients were recorded in patient-specific sheets. Considering these data, the survival ra.. Read More»
  

  Abstract PDF